These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 23383297)
1. 11β-hydroxysteroid dehydrogenase type 1 gene knockout attenuates atherosclerosis and in vivo foam cell formation in hyperlipidemic apoE⁻/⁻ mice. García RA; Search DJ; Lupisella JA; Ostrowski J; Guan B; Chen J; Yang WP; Truong A; He A; Zhang R; Yan M; Hellings SE; Gargalovic PS; Ryan CS; Watson LM; Langish RA; Shipkova PA; Carson NL; Taylor JR; Yang R; Psaltis GC; Harrity TW; Robl JA; Gordon DA PLoS One; 2013; 8(2):e53192. PubMed ID: 23383297 [TBL] [Abstract][Full Text] [Related]
2. Decreased OxLDL uptake and cholesterol efflux in THP1 cells elicited by cortisol and by cortisone through 11β-hydroxysteroid dehydrogenase type 1. Ledda A; González M; Gulfo J; Díaz Ludovico I; Ramella N; Toledo J; Garda H; Grasa M; Esteve M Atherosclerosis; 2016 Jul; 250():84-94. PubMed ID: 27187933 [TBL] [Abstract][Full Text] [Related]
3. 11β-Hydroxysteroid dehydrogenase type 1 contributes to the balance between 7-keto- and 7-hydroxy-oxysterols in vivo. Mitić T; Shave S; Semjonous N; McNae I; Cobice DF; Lavery GG; Webster SP; Hadoke PW; Walker BR; Andrew R Biochem Pharmacol; 2013 Jul; 86(1):146-53. PubMed ID: 23415904 [TBL] [Abstract][Full Text] [Related]
4. Macrophages from 11beta-hydroxysteroid dehydrogenase type 1-deficient mice exhibit an increased sensitivity to lipopolysaccharide stimulation due to TGF-beta-mediated up-regulation of SHIP1 expression. Zhang TY; Daynes RA J Immunol; 2007 Nov; 179(9):6325-35. PubMed ID: 17947710 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice. Du F; Yu F; Wang Y; Hui Y; Carnevale K; Fu M; Lu H; Fan D Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):759-67. PubMed ID: 24504735 [TBL] [Abstract][Full Text] [Related]
6. 11β-HSD1 inhibition reduces atherosclerosis in mice by altering proinflammatory gene expression in the vasculature. Luo MJ; Thieringer R; Springer MS; Wright SD; Hermanowski-Vosatka A; Plump A; Balkovec JM; Cheng K; Ding GJ; Kawka DW; Koo GC; Grand CB; Luo Q; Maletic MM; Malkowitz L; Shah K; Singer I; Waddell ST; Wu KK; Yuan J; Zhu J; Stepaniants S; Yang X; Lum PY; Wang IM Physiol Genomics; 2013 Jan; 45(1):47-57. PubMed ID: 23170035 [TBL] [Abstract][Full Text] [Related]
7. 11β-hydroxysteroid dehydrogenase type 1 deficiency in bone marrow-derived cells reduces atherosclerosis. Kipari T; Hadoke PW; Iqbal J; Man TY; Miller E; Coutinho AE; Zhang Z; Sullivan KM; Mitic T; Livingstone DE; Schrecker C; Samuel K; White CI; Bouhlel MA; Chinetti-Gbaguidi G; Staels B; Andrew R; Walker BR; Savill JS; Chapman KE; Seckl JR FASEB J; 2013 Apr; 27(4):1519-31. PubMed ID: 23303209 [TBL] [Abstract][Full Text] [Related]
8. Retinoic acid induces macrophage cholesterol efflux and inhibits atherosclerotic plaque formation in apoE-deficient mice. Zhou W; Lin J; Chen H; Wang J; Liu Y; Xia M Br J Nutr; 2015 Aug; 114(4):509-18. PubMed ID: 26201974 [TBL] [Abstract][Full Text] [Related]
9. Tofacitinib ameliorates atherosclerosis and reduces foam cell formation in apoE deficient mice. Wang Z; Wang S; Wang Z; Yun T; Wang C; Wang H Biochem Biophys Res Commun; 2017 Aug; 490(2):194-201. PubMed ID: 28601639 [TBL] [Abstract][Full Text] [Related]
10. Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice. Bogachev O; Majdalawieh A; Pan X; Zhang L; Ro HS Mol Med; 2011; 17(9-10):1056-64. PubMed ID: 21687917 [TBL] [Abstract][Full Text] [Related]
11. Amelioration of Hyperglycemia with a Sodium-Glucose Cotransporter 2 Inhibitor Prevents Macrophage-Driven Atherosclerosis through Macrophage Foam Cell Formation Suppression in Type 1 and Type 2 Diabetic Mice. Terasaki M; Hiromura M; Mori Y; Kohashi K; Nagashima M; Kushima H; Watanabe T; Hirano T PLoS One; 2015; 10(11):e0143396. PubMed ID: 26606676 [TBL] [Abstract][Full Text] [Related]